Cargando…
Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors
The long-term management of patients with inflammatory bowel disease (IBD) is still a matter of debate, and no clear guidelines have been issued. In clinical practice, gastroenterologists often have to deal with patients in prolonged remission after immunomodulatory or immunosuppressive therapies. W...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198103/ https://www.ncbi.nlm.nih.gov/pubmed/37214561 http://dx.doi.org/10.12998/wjcc.v11.i12.2657 |